The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from Business Wire

Law Offices of Howard G. Smith Announces Investigation of Abbott Laboratories

Wednesday, November 30, 2011

Law Offices of Howard G. Smith Announces Investigation of Abbott Laboratories16:30 EST Wednesday, November 30, 2011 BENSALEM, Pa. (Business Wire) -- Law Offices of Howard G. Smith announces that it is investigating potential claims against Abbott Laboratories (“Abbott” or the “Company”) (NYSE:ABT) and its Board of Directors concerning possible breaches of fiduciary duties by the Company or its fiduciaries. Abbott engages in the discovery, development, manufacture and sale of health care products worldwide. The investigation concerns whether the Company or its fiduciaries breached their fiduciary duties related to Abbott's sales and marketing activities for Depakote, an anti-seizure medication also approved for the treatment of manic episodes associated with bipolar disorder and for prophylactic treatment of migraine headaches. Specifically, the investigation is related to the Company's disclosure of an investigation by the United States Department of Justice (DOJ), through the Unites States Attorney for the Western District of Virginia, into Abbott's sales and marketing of Depakote, and whether the Company promoted Depakote for unauthorized uses. On October 19, 2011, the Company announced that it had reserved $1.5 billion of litigation reserves “related to ongoing settlement discussions” in the DOJ's investigation related to Depakote. The Company further announced that until the settlement discussions are concluded, “there can be no certainty about definitive resolution.” The next day, October 20, 2011, The Wall Street Journal reported that if a final Depakote settlement requires Abbott to pay $1.5 billion, “it would be one of the largest such resolutions in the drug industry.” If you are a shareholder of Abbott, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, Toll Free at (888) 638-4847, or by email to, or visit our website at Law Offices of Howard G. SmithHoward G. Smith, Esquire(215) 638-4847(888)